Eiko LifeSciences (ELL) has entered into an memorandum of understanding (MoU) with Vivacious Pharmatex (VPPL) to make strategic investment in VPPL by way of acquiring 5% equity stake in VPPL. Besides the amount of Strategic investment, the expected additional outlay on account of Capital Expenditure, research and development will be approximately Rs 3 crore.
ELL will assist VPPL in identifying, developing, and promoting new products and marketing thereof in the interest of both the companies. Both VPPL and ELL to use their manufacturing facilities/ expanded capacities to manufacture the products identified and developed by ELL. ELL will be the preferred source of supply for some the key Raw Materials to VPPL at ‘Arm’s Length’ transaction.
Eiko LifeSciences is a leading manufacturer, supplier and exporter of Speciality Chemicals and Pharma Intermediates in India and Globally.
| Company Name | CMP |
|---|---|
| BASF India | 3680.00 |
| Tata Chemicals | 821.05 |
| SRF | 2634.95 |
| Pidilite Inds. | 1384.00 |
| Deepak Nitrite | 1771.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: